CPRIT PDR — Texas Device and Diagnostics Company
Funds Texas firms developing cancer diagnostics, companion tools, and biomarkers for clinical deployment.
The CPRIT Texas Device and Diagnostics Company RFA is a Product Development Research mechanism administered by the Cancer Prevention and Research Institute of Texas, which allocates approximately $70 million per fiscal year across its four product development tracks. The Device and Diagnostics RFA funds Texas-based for-profit companies developing devices and assays for cancer detection, diagnosis,…
Cancer detection, diagnosis, prognosis, monitoring, and treatment devices and assays — including companion diagnostics and early-lesion tests — for Texas companies near regulatory submission.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline